Feroci F, Lenzi E, Kröning K C, Moraldi L, Cantafio S, Borrelli A, Giaconi G, Scatizzi M
Unità Operativa di Chirurgia Generale, Ospedale Misericordia e Dolce, Prato, Italia.
Minerva Chir. 2011 Feb;66(1):41-8.
Despite the laparoscopic right hemicolectomy has been validated by many randomized prospective trials, clear evidences on the validity of the totally mini-invasive technique, namely, through intracorporeal anastomosis, are still lacking. The aim of this study was the assessment of short-term outcome within three months from laparoscopic right colectomy with intra- or extra-corporeal anastomosis.
With no exclusion, all patients undergoing laparoscopic right hemicolectomy at our institution have been enrolled in this study. Group A included patients undergoing laparoscopic right hemicolectomy with extracorporeal anastomosis (LAC) and Group B, included patients undergoing laparoscopic right hemicolectomy with intracorporeal anastomosis (TLC). Patients' data, surgery details, results of postoperative period and histological tests have been prospectively recorded in a database and analysed.
Between December 2006 and December 2008, 45 patients underwent right hemicolectomy, 21 with extracorporeal anastomosis and 24 had intracorporeal ones. As to patients' characteristics and histopathological results there are no difference between the groups. Anastomotic dehiscence occurred one in group A and one in group B (P>0.05). Both patients underwent reoperation. We recorded 6 postoperative ileus with vomiting in the LAC group and only 1 in the TLC group (P<0.05). The incidence of Non-Surgical Site Complications (NSSC) was of 4.54% in LAC group and 8.33% in TLC group (P>0.05). Hospitalization was of 5 days for both groups.
In conclusion, we believe that this technique is feasible in terms of safety; it doesn't significatively affect the length of surgical procedure and guarantees maintenance of oncological radicality standards of reference. Besides it significatively improves quality of the post-operative period.
尽管腹腔镜右半结肠切除术已被多项随机前瞻性试验所验证,但关于完全微创技术(即通过体内吻合)有效性的确切证据仍然缺乏。本研究的目的是评估腹腔镜右半结肠切除术采用体内或体外吻合术后三个月内的短期结果。
本研究纳入了在我们机构接受腹腔镜右半结肠切除术的所有患者,无排除标准。A组包括接受体外吻合的腹腔镜右半结肠切除术(LAC)的患者,B组包括接受体内吻合的腹腔镜右半结肠切除术(TLC)的患者。患者数据、手术细节、术后结果和组织学检查结果已前瞻性地记录在数据库中并进行分析。
2006年12月至2008年12月期间,45例患者接受了右半结肠切除术,21例采用体外吻合,24例采用体内吻合。两组患者的特征和组织病理学结果无差异。A组和B组各有1例发生吻合口裂开(P>0.05)。两名患者均接受了再次手术。我们记录到LAC组有6例术后肠梗阻伴呕吐,而TLC组仅有1例(P<0.05)。LAC组非手术部位并发症(NSSC)的发生率为4.54%,TLC组为8.33%(P>0.05)。两组的住院时间均为5天。
总之,我们认为该技术在安全性方面是可行的;它不会显著影响手术时间,并保证维持肿瘤根治性标准。此外,它还能显著改善术后质量。